000			01630nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aSystemic Autoinflammatory Diseases—Clinical Rheumatic Challenges
546			_aEnglish[eng]
650			_agout||febuxostat||colchicine||hepatotoxicity||prophylaxis||myositis||inflammatory idiopathic myopathy||dysphagia||aspiration||pneumonia||immunoglobulin G4-related orbital disease (IgG4-ROD)||orbital lymphoma (OL)||computed tomography (CT)||Hounsfield unit||imaging||autoinflammation||arthritis||CAPS||FCAS||MWS||CINCA||NOMID||hearing loss||urticarial-like rash||autoinflammatory disease||anti-IL-1 treatment||rheumatoid arthritis||synovitis||neoplasms||edema||inflammation||new genetic variant||monogenic autoinflammatory syndrome||diagnostic delay||anakinra||damage index||genetic inheritance||personalized therapy||Interleukin-1||autoinflammatory diseases||FMF||coronavirus||SARS-CoV-2 antibody response||adult-onset Still’s disease||autoinflammatory disorder||systemic-onset juvenile idiopathic arthritis||haemophagocytic lymphohistiocytosis||macrophage activation syndrome||IFN-γ||JAK inhibitor||proliferation||DNA damage repair||γH2AX||PBMCs||T lymphocytes||proteasome||autoimmune||proteasome-associated autoinflammatory syndrome||therapy||IL-1 inhibitors||NGS||SURF||spondyloarthritis||human leukocyte antigen||undifferentiated enthesitis and/or arthritis||ASAS classification criteria||clinical management||canakinumab||cytokines||n/a
700			_aFeist, Eugen
856			_uhttps://mdpi.com/books/pdfview/book/4695
942			_cEB
999			_c30775 _d30775